DRIVE WEALTH MANAGEMENT, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1952781
LEHI, UT
Position in REGN
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$324,508
+$36,601 QoQ
Shares Held
420
+12.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $2,015,581 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,919 | $953,224 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
2,773 | $317,979 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,990 | $254,717 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
7,085 | $250,737 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,338 | $236,029 | |
| 6 | GOSS |
Gossamer Bio, Inc.
|
17,550 | $2,895 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $324,508 | 420 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $287,907 | 373 | Shares | Other | 2026-02-04 | |
| 2024-12-31 | $241,479 | 339 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $360,574 | 343 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $348,941 | 332 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $311,846 | 324 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $273,148 | 311 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $246,065 | 299 | Shares | Sole | 2023-10-11 | |
| 2023-03-31 | $201,309 | 245 | Shares | Sole | 2023-04-13 | |
| No filing history on record for this holder in this stock. | ||||||